- Investing Ideas
- /
- Belgian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Belgian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
5
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
5 companies
Financière de Tubize
Market Cap: €7.1b
Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.
TUB
€158.60
7D
-3.9%
1Y
20.2%
UCB
Market Cap: €37.3b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€196.50
7D
-3.4%
1Y
19.9%
argenx
Market Cap: €36.9b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€603.20
7D
-2.5%
1Y
26.6%
Hyloris Pharmaceuticals
Market Cap: €167.4m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€5.98
7D
-2.3%
1Y
2.4%
Celyad Oncology
Market Cap: €13.7m
A biotechnology company, focuses on the research and development of chimeric antigen receptor T cell (CAR T) therapies for cancer.
CYAD
€0.31
7D
2.0%
1Y
14.1%